SCHEDULE 13G/A 0001193125-22-034420 0000059478 XXXXXXXX LIVE 1 Ordinary Shares 09/30/2025 0001671927 Immunocore Holdings plc 54258D105 90 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY Rule 13d-1(d) ELI LILLY & Co IN 0.00 0.00 0.00 0.00 0.00 0.0 CO ELI LILLY S.A. V8 0.00 0.00 0.00 0.00 0.00 0.0 CO Immunocore Holdings plc 90 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, UNITED KINGDOM, OX14 4RY. Eli Lilly S.A. Eli Lilly and Company c/o Lilly Corporate Center Indianapolis, Indiana 46285 Eli Lilly S.A. Switzerland societe anonyme Eli Lilly and Company Indiana corporation Y See Item 9 of Cover Sheet. See Item 11 of Cover Sheet. See Item 5 of Cover Sheet. See Item 6 of Cover Sheet. See Item 7 of Cover Sheet. See Item 8 of Cover Sheet. Y Y Y Y Y Y ELI LILLY & Co /s/ Christopher Anderson 10/03/2025 ELI LILLY S.A. /s/ Christopher Anderson 10/03/2025 This Schedule 13G/A was executed pursuant to a power of attorney for Eli Lilly and Company previously filed with the Securities and Exchange Commission, and hereby incorporated by reference herein. The power of attorney was filed as Exhibit 99.3 to a filing on Schedule 13G for the Issuer on February 10, 2022. This Schedule 13G/A was executed pursuant to a power of attorney for Eli Lilly S.A. previously filed with the Securities and Exchange Commission, and hereby incorporated by reference herein. The power of attorney was filed as Exhibit 99.2 to a filing on Schedule 13G for the Issuer on February 10, 2022.